Q0139 Ferumoxytol, esrd use
Also known as: Feraheme, ferumoxytol for dialysis
Ferumoxytol injection specifically designated for use in end-stage renal disease patients on hemodialysis for iron replacement therapy.
In Plain Language
dialysis iron treatment; IV iron for kidney patients
Clinical Context
Used in end-stage renal disease patients on hemodialysis who develop iron deficiency anemia. Provides efficient iron delivery with minimal hemodynamic effects compared to other IV iron formulations.
RVU Information
CPT Q0139 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0139?
CPT Q0139 (Ferumoxytol, esrd use) is a Q Codes code. Ferumoxytol injection specifically designated for use in end-stage renal disease patients on hemodialysis for iron replacement therapy.
Is Q0139 covered by insurance?
Q0139 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in end-stage renal disease patients on hemodialysis who develop iron deficiency anemia. Provides efficient iron delivery with minimal hemodynamic effects compared to other IV iron formulations.
When is CPT Q0139 used?
Used in end-stage renal disease patients on hemodialysis who develop iron deficiency anemia. Provides efficient iron delivery with minimal hemodynamic effects compared to other IV iron formulations.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.